We analyzed public datasets, finding a high expression level of both HK2 and MMP-1/2/9/13/14 in benign PNs of NF1 patients (Figure 3F), disclosing the possibility of starting treatments with HK2peps before these tumors switch to the malignant phenotype. This evidence concerns the gene HK2 and neurofibromatosis type 1.